Alnylam Pharmaceuticals, Inc. (ALNY): Weighted Average Diluted Shares
134.68M
Year ended 2025-12-31
+3.4%
3-year compound annual growth
+3.2%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 134.68M | +5.5% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | 127.65M | +2.2% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | 124.91M | +2.6% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | 121.69M | +2.7% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | 118.45M | +3.0% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | 114.99M | +5.2% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | 109.26M | n/a | 2022-02-10, From 2019-01-01 |